Seems very positive, as i said i believe long term ICP is in a very strong position, particularly if China negotions come through.I beieve this will begin to attract some attention from buyers.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
